Medicare Enrolled
Dr. Shubha Kollampare, MD
Rheumatology · Clermont, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kollampare from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kollampare?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kollampare
Dr. Shubha Kollampare is a rheumatology specialist in Clermont, FL, with 14 years of NPI registration. Based on federal Medicare data, Dr. Kollampare performed 176,149 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kollampare received a total of $6,638 from 34 pharmaceutical and/or device companies across 340 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kollampare is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years of NPI registration
▲ Top 11% volume in FL
$6,638 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 153239 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗176,149
Medicare services
Top 11% in FL for rheumatology
Not available
Unique patients (not deduplicated)
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
67,600 | $4 | $13 |
| Tocilizumab injection (Actemra) | 52,320 | $5 | $11 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
32,175 | $34 | $72 |
| Romosozumab injection (Evenity) for osteoporosis | 13,440 | $8 | $16 |
| Denosumab injection (Prolia/Xgeva) | 3,600 | $19 | $37 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,296 | $8 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,103 | $97 | $200 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
673 | $1 | $10 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
584 | $101 | $250 |
| Methotrexate sodium, 5 mg | 581 | $0 | $10 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
553 | $56 | $115 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
414 | $4 | $15 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
286 | $133 | $250 |
| X-ray of hand, 2 views An X-ray imaging test of the hand using two different angles to visualize the bones and joints. |
157 | $23 | $65 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
137 | $49 | $105 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
116 | $46 | $110 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
106 | $66 | $150 |
| Foot X-ray, 3+ views An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints. |
94 | $25 | $50 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
83 | $37 | $200 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
80 | $1 | $25 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
72 | $121 | $260 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
70 | $22 | $75 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
65 | $11 | $40 |
| Knee X-ray, 1-2 views An X-ray imaging test of the knee joint using one to two different angles to visualize the bones and surrounding structures. |
57 | $25 | $50 |
| MRI of arm without contrast An MRI scan of the arm that uses magnetic fields and radio waves to create detailed images of internal structures without the use of contrast dye. |
56 | $179 | $750 |
| X-ray of upper spine, 4-5 views An X-ray imaging test of the upper spine using 4 to 5 different views to visualize the bones and structures in that area. |
50 | $39 | $90 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
48 | $17 | $60 |
| MRI of arm joint, without contrast An MRI scan uses magnetic fields and radio waves to create detailed images of the arm joint. This specific procedure is performed without the use of a contrast dye. |
47 | $112 | $750 |
| Tendon or ligament injection A procedure involving the injection of medication into a tendon or ligament. |
45 | $37 | $110 |
| New patient office visit, complex (60-74 min) | 40 | $159 | $320 |
| Hip X-ray, 2-3 views An X-ray imaging test of the hip joint using two to three different angles to visualize the bones and surrounding structures. |
34 | $37 | $80 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
26 | $27 | $65 |
| Joint fluid aspiration or injection, small joint Removal of fluid from a small joint or injection of medication into a small joint. |
22 | $36 | $80 |
| X-ray of lower and sacral spine, minimum of 4 views An X-ray imaging test of the lower back and sacrum using at least four different angles to visualize the bones and joints. |
22 | $40 | $120 |
| X-ray of sacroiliac joint, 1-2 views An X-ray imaging test of the joint connecting the lower spine to the hip bone, using one to two images. |
22 | $26 | $80 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
21 | $12 | $40 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
21 | $1 | $5 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
20 | $3 | $20 |
| Urine analysis Laboratory testing of a urine sample to check for various substances and conditions, excluding immunoassay tests. |
13 | $2 | $10 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
18.6% high complexity
78.8% medium
2.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,638
Total received (2018-2024)
Avg $948/year across 7 years
Top 49% in FL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
340
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$228
2023
$2,278
2022
$1,797
2021
$449
2020
$148
2019
$1,630
2018
$108
Payments by company (2024)
Amgen Inc.
$51
UCB, Inc.
$50
Janssen Biotech, Inc.
$43
AstraZeneca Pharmaceuticals LP
$30
PFIZER INC.
$25
Lilly USA, LLC
$15
ABBVIE INC.
$14
Top 3 companies account for 62.9% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,107
UCB, Inc.
$878
Janssen Biotech, Inc.
$711
AstraZeneca Pharmaceuticals LP
$472
ABBVIE INC.
$435
GlaxoSmithKline, LLC.
$417
PFIZER INC.
$305
Flexion Therapeutics, Inc.
$295
Horizon Therapeutics plc
$282
Radius Health, Inc.
$243
Novartis Pharmaceuticals Corporation
$211
Lilly USA, LLC
$186
Boehringer Ingelheim Pharmaceuticals, Inc.
$156
Janssen Scientific Affairs, LLC
$120
AbbVie Inc.
$116
AbbVie, Inc.
$82
Mallinckrodt Enterprises LLC
$81
GENZYME CORPORATION
$76
E.R. Squibb & Sons, L.L.C.
$74
Genentech USA, Inc.
$68
Sandoz Inc.
$41
Celgene Corporation
$39
Alexion Pharmaceuticals, Inc.
$37
Mallinckrodt LLC
$30
Fresenius Kabi USA, LLC
$25
Mallinckrodt Hospital Products Inc.
$23
Bioventus LLC
$22
Aurinia Pharma U.S., Inc.
$20
Lundbeck LLC
$16
ANI Pharmaceuticals, Inc.
$15
DePuy Synthes Sales Inc.
$15
Mitsubishi Tanabe Pharma America, Inc.
$13
Kiniksa Pharmaceuticals, Ltd.
$13
Orthogenrx Inc.
$11
Top 3 companies account for 40.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Arcalyst · BENLYSTA · Briviact · COSENTYX · CYLTEZO · Cimzia · EVENITY · EVUSHELD · Enbrel · GELSYN-3 · GenVisc 850 · HUMIRA · HYRIMOZ · Humira · ILARIS · KEVZARA · KRYSTEXXA · LUPKYNIS · LYRICA · OFEV · ORENCIA · ORTHOVISC · Otezla · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RINVOQ · Radicava · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · Tymlos · VYEPTI · XELJANZ · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
30
County median income
$69,956
Nearest hospital to ZIP centroid (approximate)
ORLANDO HEALTH SOUTH LAKE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kollampare is a mixed practice specialist, with above-average Medicare volume (top 11% in FL).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kollampare experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Kollampare performed 67,600 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kollampare receive payments from pharmaceutical companies?
Yes. Dr. Kollampare received a total of $6,638 from 34 companies across 340 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kollampare's costs compare to other rheumatologists in Clermont?
Dr. Kollampare's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kollampare) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Clermont
Browse rheumatologists in Clermont ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in FL
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in FL
Which FL rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology